File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.autrev.2009.01.014
- Scopus: eid_2-s2.0-67349172922
- PMID: 19393215
- WOS: WOS:000267567300005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique
Title | Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique |
---|---|
Authors | |
Keywords | Autoimmune anomalies Modified vaccination technique Prophylactic Therapeutic Tolerance to self |
Issue Date | 2009 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/autrev |
Citation | Autoimmunity Reviews, 2009, v. 8 n. 7, p. 552-557 How to Cite? |
Abstract | Our research group has developed a new vaccination technique in experimental animals that has the potential of correcting autoimmune anomalies in humans such as autoimmune disorders, cancer, and chronic infections, both prophylactically and therapeutically. The vaccination method is called Modified Vaccination Technique (MVT). The MVT necessitates the introduction of a purified target antigen (ag) and a specific antibody (ab) against the target ag in the form of immune complex (IC) to evoke the desired immune response outcome by ab information transfer in the injected recipient. The injected IC produces the same class of ab in the host, with the same specificity against the target ag, as resides in the inoculum. The MVT promises to provide a means of upregulating beneficial immune events and downregulating undesirable immune responses in individuals, thereby re-establishing normalcy/tolerance to self. © 2009 Elsevier B.V. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/132548 |
ISSN | 2023 Impact Factor: 9.2 2023 SCImago Journal Rankings: 2.677 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Barabas, AZ | en_HK |
dc.contributor.author | Cole, CD | en_HK |
dc.contributor.author | Barabas, AD | en_HK |
dc.contributor.author | Graeff, RM | en_HK |
dc.contributor.author | Lafreniere, R | en_HK |
dc.contributor.author | Weir, DM | en_HK |
dc.date.accessioned | 2011-03-28T09:26:11Z | - |
dc.date.available | 2011-03-28T09:26:11Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | Autoimmunity Reviews, 2009, v. 8 n. 7, p. 552-557 | en_HK |
dc.identifier.issn | 1568-9972 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/132548 | - |
dc.description.abstract | Our research group has developed a new vaccination technique in experimental animals that has the potential of correcting autoimmune anomalies in humans such as autoimmune disorders, cancer, and chronic infections, both prophylactically and therapeutically. The vaccination method is called Modified Vaccination Technique (MVT). The MVT necessitates the introduction of a purified target antigen (ag) and a specific antibody (ab) against the target ag in the form of immune complex (IC) to evoke the desired immune response outcome by ab information transfer in the injected recipient. The injected IC produces the same class of ab in the host, with the same specificity against the target ag, as resides in the inoculum. The MVT promises to provide a means of upregulating beneficial immune events and downregulating undesirable immune responses in individuals, thereby re-establishing normalcy/tolerance to self. © 2009 Elsevier B.V. All rights reserved. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/autrev | en_HK |
dc.relation.ispartof | Autoimmunity Reviews | en_HK |
dc.subject | Autoimmune anomalies | en_HK |
dc.subject | Modified vaccination technique | en_HK |
dc.subject | Prophylactic | en_HK |
dc.subject | Therapeutic | en_HK |
dc.subject | Tolerance to self | en_HK |
dc.title | Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Graeff, RM: graeffr@hku.hk | en_HK |
dc.identifier.authority | Graeff, RM=rp01464 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.autrev.2009.01.014 | en_HK |
dc.identifier.pmid | 19393215 | - |
dc.identifier.scopus | eid_2-s2.0-67349172922 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-67349172922&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 8 | en_HK |
dc.identifier.issue | 7 | en_HK |
dc.identifier.spage | 552 | en_HK |
dc.identifier.epage | 557 | en_HK |
dc.identifier.isi | WOS:000267567300005 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Barabas, AZ=7005562572 | en_HK |
dc.identifier.scopusauthorid | Cole, CD=8942475100 | en_HK |
dc.identifier.scopusauthorid | Barabas, AD=7005562583 | en_HK |
dc.identifier.scopusauthorid | Graeff, RM=7003614053 | en_HK |
dc.identifier.scopusauthorid | Lafreniere, R=7006983863 | en_HK |
dc.identifier.scopusauthorid | Weir, DM=7202838101 | en_HK |
dc.identifier.citeulike | 5468944 | - |
dc.identifier.issnl | 1568-9972 | - |